Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.25B
Enterprise Value7.73B
P/E Ratio17.67
PEG Ratio-0.85
Price/Sales Ratio3.56
Price/Book Ratio2.2
Enterprise/Revenue3.37
Enterprise/EBITDA10.5

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.2
Operating Margin0.26
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.12

Income Statement

Revenue2.05B
Revenue/Share3.43
Gross Profit1.56B
EBITDA654.91M
Net Income433.13M
Diluted EPS0.74

Balance Sheet

Total Cash1.4B
Total Cash/Share2.38
Total Debt302.21M
Total Debt/Equity0.09
Current Ratio4.92
Book Value Per Share5.56

Price History

52-Week Change-16.93
52-Week High15.75
52-Week Low11.91
Moving Average 50 Days12.76
Moving Average 200 Days13.64

Statistics

Average Volume2.34M
Shares Outstanding587.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4.09
Payout Ratio0.76
Last Split Factor13:10
Last Split DateApril 21, 2011
AD